The drug and insurance industries have amped up their efforts to lobby Congress, spending millions over a three-month period to influence legislation aimed at reshaping the nation's healthcare system, new reports show. America's Health Insurance Plans, for example, racked up $6.3 million in lobbying expenses this year—$1 million more than the same period in 2008, according to lobbying reports.